Down at about 106 we believe we have early buyers who are trying to buy the 3 , 4 H time frame $$...so here's another model let's see if it's gonna play... Patience Patience Patience...
NASDAQ:OM fundamentals: - 10,000 TPS - Cosmos SDK - Regulatory compliant - Billions in real deals No other L1 has this. Current price is a gift. $12 incoming ? #MANTRA
GBPUSD Long Trade Idea on M15 Market Structure . Confluence: M15 Liq. Sweep >fractal CHoch >structure Shift >best poi with fvg
All NASDAQ:OM holders will be rewarded. DAMAC chose #MANTRA after their FWB:20B US expansion plan. The only L1 doing billion-dollar RWA deals. Just accumulate.
Other L1s promise RWA future. NASDAQ:OM delivers it now: - DAMAC's billions being tokenized - Right after their FWB:20B US plan - Fully regulated chain Real adoption > empty promises #MANTRA #RWAs
Added a gem to watchlist ? NASDAQ:OM || @MANTRA_Chain NARRATIVE: Regulated RWA Layer-1 ➤ First L1 tokenizing billions with DAMAC ➤ DAMAC's timing: FWB:20B US expansion ➝ MANTRA deal ➤ Real institutional adoption ➤ Only regulated chain focused on RWA ➤ Untapped trillion-dollar market ➤ Still undervalued vs other L1s #Altcoins #Whales #MANTRA #RWAs
I'm buying CRYPTOCAP:PEPE here. I've been waiting for an SFP at these lows or a touch of the orange line (though it might not reach). I'd rather start longing now and not miss out if the other bids don’t fill. Both the daily and weekly charts show good potential for a reversal. Overall, this is a solid level to enter. BINANCE:PEPEUSDT
Which L1 has REAL institutional adoption? @MANTRA_Chain: - DAMAC (fresh off FWB:20B US announcement) - MAG ($500M real estate) - Novus Aviation - Google Cloud - Zand Bank - Multiple SEED_TVCODER77_ETHBTCDATA:1B + deals NASDAQ:OM - Clear path to Top 15. $15+ inevitable. #MANTRA #OM #RWA
bought some avaai around this area 0.15++ let see how it plays.
Intuitive Surgical, Inc. (ISRG) experienced a 2% dip in premarket trading on Friday despite reporting robust fourth-quarter earnings that exceeded analysts’ expectations. The medical device company, known for its revolutionary da Vinci surgical robots, continues to showcase its dominance in the minimally invasive surgery market. Here’s a detailed look at the company’s performance, supported by fundamental and technical insights. Strong Financial Performance Intuitive Surgical reported a 25% year-over-year increase in fourth-quarter revenue, reaching $2.41 billion. This figure surpassed the consensus estimate compiled by Visible Alpha, reinforcing the company’s strong growth trajectory. Earnings rose to $686 million, or $1.88 per share, up from $606 million, or $1.69 per share, a year ago. These figures also beat analysts’ expectations, demonstrating the company’s profitability. Operational Highlights Procedure Growth: The number of procedures performed using da Vinci surgical devices increased by 18% year-over-year, signaling strong demand for Intuitive Surgical’s minimally invasive technology. System Installations: The company installed 493 da Vinci systems during the quarter, compared to 415 systems a year earlier. This growth highlights the increasing adoption of its surgical solutions. Future Outlook Intuitive Surgical expects da Vinci procedures to grow by 13% to 16% in 2025. However, the company anticipates a 1 to 2 percentage point decline in its adjusted gross profit margin due to potential new tariffs, which could materially impact its financials. Technical Analysis Despite the strong earnings report, NASDAQ:ISRG shares fell by 2% in premarket trading. The stock’s overbought condition, indicated by an RSI of 75 as of Thursday’s close, suggests a potential for short-term correction. - Gap Down Pattern: Historically, gap-down patterns in NASDAQ:ISRG stock have been filled, hinting at a possible rebound in the coming sessions. This historical behavior aligns with the broader market’s tendency to correct temporary gaps. Key Support and Resistance Levels - Support: Immediate support lies at the 38.2% Fibonacci retracement level, which could act as a cushion in case of further price correction. - Resistance: The pivot point is situated above the 1-month high, presenting a significant barrier for upward momentum. Moving Averages The stock is trading above its 50-day, 100-day, and 200-day moving averages, underscoring its bullish trend in the medium to long term. This alignment of key moving averages strengthens the case for continued upside potential. Market Context - All-Time High: NASDAQ:ISRG shares closed at an all-time high on Thursday, marking a 62% gain over the past year. This performance underscores investor confidence in the company’s long-term prospects. - Sector Strength: The growing adoption of robotic surgical systems positions Intuitive Surgical as a leader in the medical device industry, benefiting from the broader trend toward minimally invasive procedures. Conclusion Intuitive Surgical’s robust financial results and operational milestones underscore its leadership in the surgical robotics market. While the current dip in premarket trading reflects short-term market dynamics, the stock’s strong technical indicators and historical performance suggest a potential rebound. Investors should monitor key support and resistance levels, along with updates on tariff developments, to assess the stock’s trajectory. With a bullish continuation pattern likely in play, NASDAQ:ISRG remains a compelling option for long-term growth-oriented investors.